Published in Cancer Weekly, September 12th, 2006
"To detect autoantibodies that could be diagnostic markers for HCC, we analyzed serum autoantibodies comprehensively that showed immunoreactivity to proteins in tumor tissue obtained from patients with HCC. Fifteen paired samples of HCC tissue and corresponding nontumorous liver tissue as well as five normal liver tissue samples were used in the study," wrote M. Takashima and colleagues, Yamaguchi University.
They explained, "A combination of proteomics and SEREX (serologic analysis of recombinant cDNA expression...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-09-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.